Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Merricka C. Livingstone"'
Autor:
Merricka C. Livingstone, Alexis A. Bitzer, Alish Giri, Kun Luo, Rajeshwer S. Sankhala, Misook Choe, Xiaoyan Zou, S. Moses Dennison, Yuanzhang Li, William Washington, Viseth Ngauy, Georgia D. Tomaras, M. Gordon Joyce, Adrian H. Batchelor, Sheetij Dutta
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Plasmodium falciparum malaria contributes to a significant global disease burden. Circumsporozoite protein (CSP), the most abundant sporozoite stage antigen, is a prime vaccine candidate. Inhibitory monoclonal antibodies (mAbs) against CSP m
Externí odkaz:
https://doaj.org/article/f735407d93c347bfbd54ca0405a5bab5
Autor:
S. Moses Dennison, Kun Luo, Alexis A. Bitzer, Yuanzhang Li, William Washington, Rajeshwer S. Sankhala, Misook Choe, Viseth Ngauy, Alish Giri, Xiaoyan Zou, M. Gordon Joyce, Georgia D. Tomaras, Merricka C. Livingstone, Sheetij Dutta, Adrian H. Batchelor
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports
Scientific Reports
Plasmodium falciparum malaria contributes to a significant global disease burden. Circumsporozoite protein (CSP), the most abundant sporozoite stage antigen, is a prime vaccine candidate. Inhibitory monoclonal antibodies (mAbs) against CSP map to eit
Autor:
Merricka C. Livingstone, Sheetij Dutta, Andrew J. Schrader, Kimberly Soto, Monica L. Martin, Zoltan Beck, Xiaoyan Zou, Mark D Langowski, Farhat Khan, Sri Hadiwidjojo, Christopher J. Genito, Alexis A. Bitzer, Gary R. Matyas, Adrian H. Batchelor
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance RTS,S/AS01 is a circumsporozoite protein (CSP)-based malaria vaccine that confers partial protection against malaria in endemic areas. Recent reports have elucidated structures of monoclonal antibodies that bind to the central (NPNA) rep
Autor:
Merricka C. Livingstone, Natalie M. Johnson, John D. Groopman, Bill D. Roebuck, Thomas W. Kensler
Publikováno v:
Mol Carcinog
Exploration of animal models leads to discoveries that can reveal candidate biomarkers for translation to human populations. Herein, a model of hepatocarcinogenesis and protection was used in which rats treated with aflatoxin (AFB1 ) daily for 28 day
Autor:
Bill D. Roebuck, Thomas W. Kensler, Merricka C. Livingstone, Natalie M. Johnson, John D. Groopman
Publikováno v:
Molecular Carcinogenesis. 56:2382-2390
Aflatoxin B1 (AFB1) is a potent human and animal hepatocarcinogen. To investigate the effects of aflatoxin on miRNA expression during the initiation phase of carcinogenesis, next-generation sequencing was used to analyze liver tissues from F344 rats
Autor:
Merricka C, Livingstone, Natalie M, Johnson, Bill D, Roebuck, Thomas W, Kensler, John D, Groopman
Publikováno v:
Molecular carcinogenesis. 56(11)
Aflatoxin B1 (AFB1) is a potent human and animal hepatocarcinogen. To investigate the effects of aflatoxin on miRNA expression during the initiation phase of carcinogenesis, next-generation sequencing was used to analyze liver tissues from F344 rats
Autor:
Bill D. Roebuck, Thomas W. Kensler, John D. Groopman, Merricka C. Livingstone, Natalie M. Johnson
Publikováno v:
Cancer Research. 78:5401-5401
Hepatocellular carcinoma (HCC) continues to be a major cause of cancer death globally, with aflatoxin B1 (AFB1) as a prevalent risk factor in low- and middle-income countries. MicroRNAs have been shown to be differentially expressed in HCC and may se
Autor:
Bill D. Roebuck, Natalie M. Johnson, Thomas W. Kensler, Merricka C. Livingstone, John D. Groopman
Publikováno v:
Cancer Research. 76:1083-1083
Liver cancer is the second leading cause of cancer death worldwide: risk factors include the viruses, HBV and HCV, and the environmental carcinogen aflatoxin B1 (AFB1). Chemoprevention strategies that activate genes controlled by the KEAP1-NRF2 pathw